Management of ACE-Inhibitor Induced Angioedema

Initial Assessment and Airway Management

The American College of Allergy, Asthma, and Immunology recommends closely monitoring patients with oropharyngeal or laryngeal involvement in a medical facility capable of performing intubation or tracheostomy if necessary 3
Consider elective intubation if the patient exhibits signs of impending airway closure, as recommended by the American College of Allergy, Asthma, and Immunology 3
Ensure immediate availability of backup tracheostomy equipment if intubation is unsuccessful, as advised by the American College of Allergy, Asthma, and Immunology 3
Be aware that the airway anatomy may be distorted by angioedema, potentially requiring physicians highly skilled in airway management, according to the American College of Allergy, Asthma, and Immunology 3

The American Heart Association and the American College of Cardiology note that standard treatments for allergic reactions (antihistamines, corticosteroids, epinephrine) have not been shown to be reliably effective for ACE-inhibitor induced angioedema 1, 2
Consider the following medication options, as recommended by the American Heart Association:
- IV methylprednisolone 125 mg 4
- IV diphenhydramine 50 mg 4
- Ranitidine 50 mg IV or famotidine 20 mg IV 4
- If angioedema increases despite above treatments, administer epinephrine (0.1%) 0.3 mL subcutaneously or by nebulizer 0.5 mL, as advised by the American Heart Association 4
For severe cases, consider bradykinin pathway-targeted therapies, such as Icatibant (a selective bradykinin B2 receptor antagonist): 30 mg subcutaneously in the abdominal area; additional injections may be administered at 6-hour intervals (maximum 3 injections in 24 hours), as recommended by the American College of Allergy, Asthma, and Immunology 1, 4
Fresh frozen plasma has shown efficacy in some cases, though controlled studies are lacking, according to the American College of Allergy, Asthma, and Immunology 1, 3
Plasma-derived C1 esterase inhibitor (20 IU/kg) has been used successfully in some cases, as noted by the American Heart Association 4

The duration of observation should be individualized based on severity and location of angioedema, as recommended by the American College of Allergy, Asthma, and Immunology 3
Avoid direct visualization of the airway unless necessary, as trauma from the procedure can worsen angioedema, according to the American College of Allergy, Asthma, and Immunology 3

Permanently discontinue the ACE inhibitor in all patients with ACE-inhibitor induced angioedema, as recommended by the American College of Cardiology and the American Heart Association 1, 2
Be aware that the propensity to develop angioedema can continue for up to 6 weeks after discontinuation of the ACE inhibitor, according to the American College of Allergy, Asthma, and Immunology 5
Use extreme caution if considering switching to an ARB, as there is a 2-17% risk of recurrent angioedema, as noted by other medical guidelines 6
Document the ACE inhibitor allergy prominently in the patient's medical record, as advised by other medical guidelines 6

African American patients, smokers, older individuals, and females are at higher risk for ACE-inhibitor induced angioedema, according to the American College of Allergy, Asthma, and Immunology 1, 2
The mechanism of ACE-inhibitor induced angioedema involves impaired degradation of bradykinin, leading to increased plasma bradykinin levels, as explained by the American College of Allergy, Asthma, and Immunology 1, 2